Global Acne Medication Market 2022
- Piyasa Raporu
- İD: HH24429G
- Teslimat süresi: 1 İş günü
- Etiket: Acne Medication
Tanım
Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It causes whiteheads, blackheads or pimples. Acne is most common among teenagers, though it affects people of all ages. A study by StrategyHelix indicates that the global acne medication market is expected to increase by US$ 2,037.0 milyon itibaren 2022 ile 2028, garnering a CAGR of 5.2% tahmin dönemi boyunca.
Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2018-2021 ve tahmin 2028 covering key market aspects like sales value for acne medication. The global acne medication market is segmented on the basis of therapeutic class, route of administration, type, ve bölge. Based on therapeutic class, the global acne medication market is categorized into retinoids, antibiotics, hormonal agents, diğerleri. The retinoids segment captured the largest share of the market in 2021. On the basis of route of administration, the global acne medication market has been segmented into topical, oral. The topical segment held the largest share of the global acne medication market in 2021 ve tahmin dönemi boyunca payını koruması bekleniyor. Türe göre, the global acne medication market has been segmented into prescription medicine, over-the-counter (OTC) medicine. İçinde 2021, the over-the-counter (OTC) medicine segment made up the largest share of revenue generated by the acne medication market. In terms of geography, the global acne medication market has been segmented into North America, Asya Pasifik, Avrupa, Dünyanın Geri Kalanı (ROW).
The global acne medication market is highly competitive. itibariyle 2021, the major players in the global acne medication market were Allergan plc, Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK), Mylan N.V., Perrigo Company plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd.
Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the acne medication market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.
Rapor Kapsamı
Therapeutic class: retinoids, antibiotics, hormonal agents, diğerleri
Route of administration: topical, oral
Tip: prescription medicine, over-the-counter (OTC) medicine
Bölge: Kuzey Amerika, Asya Pasifik, Avrupa, Dünyanın Geri Kalanı (ROW)
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2018 ile 2028
Paydaşlar için Temel Faydalar
– Get a comprehensive picture of the global acne medication market
– Büyüme sektörlerini ve yatırım eğilimlerini belirleyin
İçindekiler
Parça 1. giriiş
– Çalışmanın kapsamı
– Çalışma periyodu
– Coğrafik kapsam
– Araştırma metodolojisi
Parça 2. Acne medication market overview
Parça 3. Market breakdown by therapeutic class
– Retinoids
– Antibiotics
– Hormonal agents
– Diğerleri
Parça 4. Market breakdown by route of administration
– Topical
– Oral
Parça 5. Market breakdown by type
– Prescription medicine
– Over-the-counter (OTC) medicine
Parça 6. Market breakdown by region
– Kuzey Amerika
– Asya Pasifik
– Avrupa
– Dünyanın Geri Kalanı (ROW)
Parça 7. Anahtar şirketler
– Allergan plc
– Bausch Health Companies Inc.
– F. Hoffmann-la Roche Ltd.
– Galderma S.A. (Nestle S.A.)
– GlaxoSmithKline Plc (GSK)
– Mylan N.V.
– Perrigo Company plc
– Pfizer Inc.
– Teva Pharmaceutical Industries Ltd.
StratejiHelix Hakkında
Sorumluluk reddi beyanı
Amerikan Doları 650